H.R.9682

Cure Hepatitis C Act of 2026

Introduced·7/14/26

Cure Hepatitis C Act of 2026 aims to eliminate hepatitis C in the U.S. by enhancing screening, treatment access, and public awareness.

The Cure Hepatitis C Act of 2026 mandates the Department of Health and Human Services to establish a subscription program for hepatitis C treatments, ensuring access for high-risk populations. It coordinates with state Medicaid and CHIP programs to verify enrollment before treatment. The Act also eliminates cost-sharing for hepatitis C treatments in Medicare Part D for plan years 2028 through 2032. Additionally, it creates a Hepatitis C Elimination Program, funds public awareness campaigns, and supports diagnostic test development.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Energy And Commerce Committee
Next
Committee decision

Sponsors

Democratic CaucusRepublican Caucus

History

Jul 14

House

Introduced in House

Jul 14

House

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.